RA
BIND

Royce & Associates’s BIND THERAPEUTICS INC BIND Stock Holding History

Royce & Associates’s Portfolio BIND Stock Details BIND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,000
Closed -$11K – 1374
2014
Q4 		$11K Buy
+2,000
New +$15K ﹤0.01% 1308
2014
Q1 		– Sell
-55,000
Closed -$830K – 1522
2013
Q4 		$830K Buy
+55,000
New +$700K ﹤0.01% 1191

Other funds holding BIND

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royce & Associates's BIND Position: Q1 2015 in Review

Royce & Associates sold out of BIND THERAPEUTICS INC (BIND) in Q1 2015, closing a stake of 2,000 shares — an estimated $11K sold.

Royce & Associates first reported a position in BIND in Q4 2013 and held it in 2 quarters. The position peaked at $830K in Q4 2013. 38 funds tracked by Wall St. Rank hold BIND as of Q1 2015.

  • Royce & Associates reported no remaining BIND THERAPEUTICS INC position as of Q1 2015 after selling out during the quarter.
  • Royce & Associates sold 2,000 BIND THERAPEUTICS INC shares in Q1 2015, an estimated $11K.
  • Royce & Associates first reported a position in BIND THERAPEUTICS INC in Q4 2013 and held it in 2 quarters.
  • Royce & Associates's BIND THERAPEUTICS INC position peaked at $830K in Q4 2013.
  • 38 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q1 2015.

Based on Royce & Associates's 13F filing for Q1 2015, filed 13 May 2015.